Assisted Reproductive Technology Market Expected to Reach USD 54.75 Billion by 2028 at a 9.7% CAGR

Assisted Reproductive Technology (ART) Market refers to medical procedures that assist individuals or couples who are facing difficulties in conceiving a child. The ART market has experienced significant growth in recent years due to increasing infertility rates, changing lifestyle patterns, and advancements in medical technologies. This market includes several procedures such as in vitro fertilization (IVF), intrauterine insemination (IUI), surrogacy, and others. The global assisted reproductive technology market size is expected to reach USD 54.75 Billion at a steady revenue CAGR of 9.7% in 2028, according to latest analysis by Emergen Research.

One of the primary drivers of the ART market is the increasing prevalence of infertility among couples. Factors such as stress, obesity, and age-related complications have led to an increase in the number of individuals seeking fertility treatments. According to the Centers for Disease Control and Prevention (CDC), approximately 6% of women aged 15-44 years in the United States have infertility-related issues.

Another factor contributing to the growth of the ART market is the changing lifestyle patterns. The increase in smoking, alcohol consumption, and consumption of processed food products have led to a rise in infertility rates. Moreover, late marriage and delayed childbirth have become a common trend in many developed countries, leading to a growing demand for fertility treatments.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/165

However, the ART market is not without its challenges. One of the biggest challenges is the high cost of fertility treatments. These treatments are often expensive and not covered by insurance, making them unaffordable for many individuals. Additionally, the ethical concerns surrounding the use of ART, such as the use of surrogacy, have also led to debates and regulatory challenges.

Despite these challenges, the ART market is expected to witness significant growth in the coming years due to several growth factors. One such factor is the increasing adoption of single-parent and same-sex parenting, leading to a higher demand for fertility treatments. Additionally, the growing number of fertility clinics and advancements in medical technologies have also contributed to the growth of the ART market.

According to a report by the Emergen Research the number of IVF treatments performed worldwide has increased from approximately 2 million in 2010 to over 3.5 million in 2019. The report also states that the average success rate of ART procedures has increased by 2-3% in the last decade.

Major Companies and Competitive Landscape :

Some major players in the market report include Origio, Cryolab Ltd., Bloom IVF Center, Ferring Pharmaceuticals, Cosmos Biomedical, Irvine Scientific, European Sperm Bank, Ovascience, Parallabs, and Microm UK Ltd.

The Assisted Reproductive Technology (ART) market is highly competitive and fragmented, with several players competing for market share. The market includes several established players, as well as new entrants, making it a highly dynamic and evolving space. Some of the key players in the market include CooperSurgical, Inc., Ferring Pharmaceuticals, Merck KGaA, Irvine Scientific, Vitrolife AB, and Cook Medical.

CooperSurgical, Inc. is one of the leading players in the ART market, offering a wide range of products and services in the field of reproductive medicine. The company's product portfolio includes IVF consumables, fertility testing and diagnostics, and embryo transfer catheters. CooperSurgical has a strong presence in North America and Europe, and its acquisitions have strengthened its market position.

Ferring Pharmaceuticals is another key player in the ART market, offering a range of products and services in the field of reproductive medicine. The company's product portfolio includes fertility drugs, fertility testing and diagnostics, and reproductive health products. Ferring Pharmaceuticals has a strong presence in Europe and Asia, and its strategic partnerships have helped it expand its market reach.

Merck KGaA is a leading player in the ART market, offering a range of products and services in the field of reproductive medicine. The company's product portfolio includes fertility drugs, IVF consumables, and fertility testing and diagnostics. Merck KGaA has a strong presence in Europe and Asia, and its acquisition of Sigma-Aldrich has strengthened its market position.

In conclusion, the ART market is highly competitive, with several established players and new entrants competing for market share. The key players in the market are focusing on innovation, partnerships, and acquisitions to expand their market reach and strengthen their position in the market. As the demand for ART procedures continues to rise, the competition in the market is expected to intensify, driving innovation and development of new products and services.

Want to learn more about the global Assisted Reproductive Technology (ART) Market ? Access the full report with just one click! https://www.emergenresearch.com/industry-report/assisted-reproductive-technology-market

Assisted Reproductive Technology (ART) Market Segmentation :

The global Assisted Reproductive Technology (ART) market has been segmented by Emergen Research based on procedure, technology, end-use, and region. The procedure segment is further divided into fresh donor, fresh non-donor, frozen donor, frozen non-donor, and egg/embryo banking. The technology segment is categorized into in-vitro fertilization (IVF), IVF with intracytoplasmic sperm injection (ICSI), IVF without ICSI, artificial insemination, frozen embryo transfer (FET), and others. The end-use segment includes hospitals, fertility clinics, and others. The regional analysis covers North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

The procedure segment of the ART market includes various categories such as fresh donor, fresh non-donor, frozen donor, frozen non-donor, and egg/embryo banking. Fresh non-donor is expected to hold the largest share of the market during the forecast period due to the high success rates of the procedure. However, egg/embryo banking is expected to witness significant growth in the coming years owing to the increasing trend of delayed pregnancies and advancements in technology.

Based on technology, the ART market is segmented into IVF, IVF with ICSI, IVF without ICSI, artificial insemination, FET, and others. The IVF segment is expected to hold the largest share of the market during the forecast period due to its high success rates and increasing adoption of this technology. However, the FET segment is expected to witness significant growth in the coming years due to the increasing trend of frozen embryo transfer.

Based on end-use, the ART market is segmented into hospitals, fertility clinics, and others. The fertility clinics segment is expected to hold the largest share of the market during the forecast period due to the increasing number of fertility clinics and rising demand for infertility treatments.

Geographically, the ART market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is expected to hold the largest share of the market during the forecast period due to the increasing adoption of ART procedures and rising prevalence of infertility in the region. However, the Asia Pacific region is expected to witness significant growth in the coming years due to the increasing

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/165

Eric Lee

Corporate Sales Specialist

14671 110 Avenue, Surrey, British Columbia, V3R2A9

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions.

This release was published on openPR.